Impact of Weight Loss During Chemotherapy in Chinese Patients with Unresectable Pancreatic Cancer

References

• American Cancer Society: Cancer facts and figures 2013. Atlanta: American Cancer Society, 2013.
   Google Scholar
• Malvezzi M, Bertuccio P, Levi F, La Vecchia C, and Negri E: European cancer mortality predictions for the year 2013. Ann Oncol 24, 792–800, 2013.
   PubMed Web of Science ®Google Scholar
• Hospital Authority HK. Top ten cancers in Hong Kong. Hong Kong: Hospital Authority, 2013. Retrieved from http://www3.ha.org.hk/cancereg/topten.html [accessed 2017 April 29th].
   Google Scholar
• Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, et al.: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364, 1817–1825, 2011.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, et al.: Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369, 1691–1703, 2013.
   PubMed Web of Science ®Google Scholar
• Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, et al.: Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 387, 545–557, 2016.
   PubMed Web of Science ®Google Scholar
• Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, et al.: Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9, 255, 2009.
   PubMedGoogle Scholar
• Davidson W, Ash S, Capra S, and Bauer J, Cancer Cachexia Study Group: Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23, 239–247, 2004.
   PubMed Web of Science ®Google Scholar
• Ross PJ, Ashley S, Norton A, Priest K, Waters JS, et al.: Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer 90, 1905–1911, 2004.
   PubMed Web of Science ®Google Scholar
• Langius JA, Bakker S, Rietveld DH, Kruizenga HM, Langendijk JA, et al.: Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer 109, 1093–1099, 2013.
   PubMed Web of Science ®Google Scholar
• Ock CY, Oh DY, Lee J, Kim TY, Lee KH, et al.: Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer. Gastric Cancer 19, 597–606, 2016.
   PubMed Web of Science ®Google Scholar
• Takayoshi K, Uchino K, Nakano M, Ikejiri K, and Baba E: Weight loss during initial chemotherapy predicts survival in patients with advanced gastric cancer. Nutr Cancer 69, 408–415, 2017.
   PubMed Web of Science ®Google Scholar
• Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, et al.: Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr 109, 302–312, 2013.
   PubMed Web of Science ®Google Scholar
• Beaver ME, Matheny KE, Roberts DB, and Myers JN: Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 125, 645–648, 2001.
   PubMed Web of Science ®Google Scholar
• Nourissat A, Bairati I, Samson E, Fortin A, Gelinas M, et al.: Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 116, 2275–2283, 2010.
   PubMed Web of Science ®Google Scholar
• Cho YW, Roh JL, Jung JH, Kim SB, Lee SW, et al.: Prediction of posttreament significant body weight loss and its correlation with disease-free survival in patients with oral squamous cell carcinomas. Nutr Cancer 65, 417–423, 2013.
   PubMed Web of Science ®Google Scholar
• Kiss N, Isenring E, Gough K, and Krishnasamy M: The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors. Clin Nutr 33, 1074–1080, 2014.
   PubMed Web of Science ®Google Scholar
• Langius JA, Twisk J, Kampman M, Doornaert P, Kramer MH, et al.: Prediction model to predict critical weight loss in patients with head and neck cancer during (chemo)radiotherapy. Oral Oncol 52, 91–96, 2016.
   PubMed Web of Science ®Google Scholar
• Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, et al.: Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage 44, 181–191, 2012.
   PubMed Web of Science ®Google Scholar
• He W, Li Q, Yang M, Jiao J, Ma X, et al.: Lower BMI cutoffs to define overweight and obesity in China. Obesity (Silver Spring) 23, 684–691, 2015.
   PubMed Web of Science ®Google Scholar
• Lam KY, Lee K, Chong C, Chan AW, Mok T, and Chan SL: A study on thromboembolism of patients with pancreatic cancer. J Clin Oncol 35, 262–262, 2017.
   Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JEA, Brown P, Cottam K, Elia M, Field J, et al.: A positive approach to nutrition as treatment. Report of a Working Party Chaired by Professor JE Lennard Jones. London, United Kingdom: Kings Fund Centre, 1992.
   Google Scholar
• Tan CR, Yaffee PM, Jamil LH, Lo SK, Nissen N, et al.: Pancreatic cancer cachexia: a review of mechanisms and therapeutics. Front Physiol 5, 88, 2014.
   PubMed Web of Science ®Google Scholar
• Ziske C, Schlie C, Gorschluter M, Glasmacher A, Mey U, et al.: Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 89, 1413–1417, 2003.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Heinzerling J, Livingston EH, and Huerta S: Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 194, 362–366, 2007.
   PubMed Web of Science ®Google Scholar
• Barber MD, Ross JA, Voss AC, Tisdale MJ, and Fearon KC: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81, 80–86, 1999.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, et al.: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52, 1479–1486, 2003.
   PubMed Web of Science ®Google Scholar
• Kraft M, Kraft K, Gartner S, Mayerle J, Simon P, et al .: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)-a randomized multicentre trial . Nutr J 11, 52, 2012.
   PubMed Web of Science ®Google Scholar
• McMillan DC, Wigmore SJ, Wigmore KCH, O’Gorman P, Wright CE, and McArdle CS: A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79, 495–500, 1999.
   PubMed Web of Science ®Google Scholar
• Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, and Goggin PM: Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54, 540–545, 2005.
   PubMed Web of Science ®Google Scholar